Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 12, 2006
Subject: Entry into a Material Definitive Agreement regarding amendments to equity compensation plans.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material change is the approval by the Compensation Committee of the Board of Directors on October 12, 2006, to amend the following agreements under the 2002 Equity Compensation Plan and the 1999 Non-Executive Officer and Non-Director Equity Compensation Plan:
- Non-Qualified Stock Option Agreements
- Restricted Stock Units Agreements
- Stock Appreciation Rights Agreements
Management Commentary and Unusual Items
The amendments introduce specific provisions regarding change of control and post-termination restrictions:
- Change of Control Vesting: Equity awards will automatically vest and become immediately exercisable or issuable in their entirety if a change of control occurs and the acquirer does not assume, convert, or replace the award. This also applies if the participant's employment is terminated without cause or for good reason within 24 months of the change of control.
- Post-Termination Restrictions: Participants are limited in their relationships with competitors, suppliers, and certain physician groups for one year following termination. Additionally, participants are prohibited from accepting employment or providing services where the disclosure of confidential information would be inevitable.
Investor Verification Checklist
- Verify the specific definitions of "change of control," "without cause," and "good reason" within the amended agreements (Exhibits 10.1 through 10.4).
- Confirm the scope of "competitors, suppliers, and certain physician groups" restricted in the post-termination clause.
- Review the impact of these amendments on the company's future equity compensation expense and potential dilution in the event of an acquisition.